The clinical-stage biotech could see its shares plummet should there be any clinical setback.
Interstellar comet 3I/ATLAS has just pulled off the kind of stunt that keeps planetary scientists humble. After racing ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data ...
Explore the full archive of TIME, a century of journalism, insight, and perspective, with AI that helps you research, connect ...
It is a central question in neuroscience to understand how different regions of the brain interact, how strongly they "talk" ...
What: Ultraviolet observations of the interstellar comet 3I/ATLAS captured by NASA’s Europa Clipper spacecraft while the ...
Public Service Commissioner Peter Hubbard takes on defeated opponent's claims about nuclear power, AI bias and consumer rates ...
XRP pushed through the $2.10 resistance zone and is developing a price structure that, if sustained, could carry Ripple’s ...